GSK
GSK plc · Healthcare · Drug Manufacturers - General
Señales de momentum (gestores comparables):
amplitud de titulares -6.7% ·
flujo de acciones +16.3% ·
nuevas posiciones netas -7.1%
· fórmula
Acumulación concentrada: acciones en aumento entre menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q1 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 163.18K | $7.64M | n/a | n/a |
| Q2 2026 | 115 | +1 | 291.71M | $15.16B | +8 | −8 |
| Q1 2026 | 116 | 0 | 315.42M | $17.28B | +8 | −8 |
| Q4 2025 | 115 | +4 | 328.16M | $15.98B | +4 | n/a |
| Q3 2025 | 18 | -1 | 242.57M | $10.47B | +1 | −3 |
| Q2 2025 | 17 | +1 | 220.73M | $8.48B | +2 | −1 |
| Q1 2025 | 14 | -1 | 157.56M | $6.11B | n/a | −1 |
| Q4 2024 | 15 | -1 | 135.53M | $4.59B | n/a | −1 |
| Q3 2024 | 15 | +3 | 120.78M | $4.99B | +3 | n/a |
| Q2 2024 | 12 | n/a | 118.47M | $4.56B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 78.65M | +14.9% | $3.05B | 1.7% | ▲ Add | 4 | SEC ↗ |
| 2 | Fisher Asset Management ✦ | 30.03M | +59.4% | $1.16B | 0.5% | ▲ Add | 4 | SEC ↗ |
| 3 | PRIMECAP Management ✦ | 25.71M | +1.8% | $995.93M | 0.8% | ▲ Add | 4 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 7.72M | +2.0% | $299.16M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 5 | State Street Global Advisors ✦ (pasivo) | 6.97M | -0.7% | $272.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 1.98M | -28.1% | $76.79M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 7 | Wellington Management ✦ | 1.92M | -8.4% | $74.30M | 0.0% | ▼ Trim | 4 | SEC ↗ ×6 |
| 8 | Citadel Advisors ✦ | 1.62M | +783.3% | $62.90M | 0.1% | ▲ Add | 4 | SEC ↗ ×2 |
| 9 | Arrowstreet Capital ✦ | 1.49M | +584.3% | $57.86M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Bridgewater Associates ✦ | 1.20M | -46.5% | $46.61M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 11 | Tweedy, Browne ✦ | 90.55K | -3.5% | $3.51M | 0.3% | ▼ Trim | 4 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 89.50K | -84.4% | $3.47M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 40.24K | +84.4% | $1.56M | 0.0% | ▲ Add | 4 | SEC ↗ ×3 |
| 14 | Millennium Management ✦ | 29.19K | -68.1% | $1.13M | 0.0% | ▼ Trim | 4 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| D. E. Shaw & Co. | $3.86M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1,022 tenedores, 373.63M acciones, $18.86B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.